Iszo Capital Management LP Landec Corp \Ca\ Transaction History

Iszo Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.0 - $9.95 $0 - $11.5 Million	-1,156,874 Reduced 75.58%	373,778 $0
Q3 2022 Nov 14, 2022	SELL	$8.57 - $11.57 $6.09 Million - $8.22 Million	-710,742 Reduced 31.71%	1,530,652 $13.6 Million
Q2 2022 Aug 15, 2022	BUY	$8.84 - $11.64 $569,693 - $750,139	64,445 Added 2.96%	2,241,394 $22.3 Million
Q1 2022 May 16, 2022	BUY	$10.07 - $11.93 $2.53 Million - $3 Million	251,638 Added 13.07%	2,176,949 $6.93 Million
Q4 2021 Feb 14, 2022	BUY	$7.95 - $11.24 $2.2 Million - $3.11 Million	276,791 Added 16.79%	1,925,311 $21.4 Million
Q3 2021 Nov 12, 2021	BUY	$9.22 - $12.44 $15.2 Million - $20.5 Million	1,648,520 New	1,648,520 $15.2 Million

20.4M

65.8K

14.1K

Ticker LNDC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 29,595,600
Description
Landec Corporation operates as a diversified health and wellness company. The company manufactures pharmaceutical-grade sodium hyaluronate (HA)-based biomaterials for primary use in the ophthalmic and orthopedic markets. It also provides product development services to its partners for HA-based, as well as non-HA based, aseptically formulated, a...

Get notified when there are updates to the investment portfolio of Iszo Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Iszo Capital Management LP with notifications on news.